Clinical Trials · NCT03038620
Impact of Liraglutide 3.0 on Body Fat Distribution
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 235
- Start date
- Jan 2017
- Locations
- 1 site, United States
- Primary endpoint
- Relative Percent Reduction in Visceral Adipose Tissue Mass Measured by MRI